Chennai

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Pfizer is the world's premier biopharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. The Company has two business verticals, viz., Regulated Markets and Emerging Markets.  Strides has a global manufacturing footprint with eight manufacturing facilities spread across four continents, including five US FDA approved facilities and two facilities for the rest of world markets. The Company has a dedicated R&D facility in India with global filing capabilities and a strong footprint across 100 countries.

The ICMR-National Institute of Epidemiology (ICMR-NIE) is a permanent premier institute of Indian Council of Medical Research (ICMR) established on July 2, 1999 by merging the Central JALMA Institute for Leprosy (CJIL Field Unit), Avadi with the Institute for Research in Medical Statistics (IRMS), Chennai.  The broad objectives of the Institute cover conducting epidemiological studies, development of human resources in epidemiology and bio-statistics, networking of the various ICMR and non-ICMR Institutes at the national level for epidemiological purposes, an

Siddha Central Research Institute (SCRI) is identified as a potential centre of excellence for clinical research. This Institute is located in the campus of Anna Government Hospital of Indian systems of Medicine and Homoeopathy at Arumbakkam, Chennai. Central Research Institute for Siddha was established in the year 1971. It has all the facilities for preclinical and clinical studies.

This Institute was established in the year from 1963 in IMPCOPS, Chennai with a motive to study the phyto-chemical aspects of medicinal plants in an around the city. Later Central Council for Research in Indian Medicine and Homeopathy had taken over this Institute as grant in aid. In the year of 1979, this institute became a part of Central Council for Research in Ayurvedic Sciences (formerly Central Council for Research in Ayurvedic and Siddha). This institute had diversified its activities to drug standardization besides phyto-chemical studies.

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Southern Railway, in its present form, came into existence on 14th April 1951 through the merger of the three state railways namely Madras and Southern Mahratta Railway, the South Indian Railway, and the Mysore state railway.  Southern Railway's present network extends over a large area of India's Southern Peninsula, covering the states of Tamilnadu, Kerala, Pondicherry,and a small portion of Andhra Pradesh.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenue comes from the international markets, particularly the highly regulated markets of the EU and the US. At Intas, everyone works to create a world of good Health, happiness and hope.

Post : Sales Manager